Loading...
OTCM
THCT
Market cap11kUSD
Oct 08, Last price  
0.00USD
1D
0.00%
1Q
-40.00%
IPO
-99.96%
Name

THC Therapeutics Inc

Chart & performance

D1W1MN
OTCM:THCT chart
P/E
—
P/S
—
EPS
—
Div yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
0
2000000000000000000
Net income
-387k
L-74.52%
-153-8,490-68,873-37,864-24,772-241,552-1,133,126-576,046-284,299-91,998-15,598,422-6,139,400-23,610,650-1,925,179-1,885,445-1,518,929-387,036
CFO
-85k
L-79.61%
147-7,997-7,437-75,655-10,983-258,500-111,246-91,782-11,919-17,318-156,733-190,165-329,803-587,933-388,477-418,917-85,432

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

THC Therapeutics, Inc. is a company active in the wellness sector, primarily engaged in developing the dHydronator. This innovative device functions as a sanitizing herb dryer, specifically designed for the efficient drying and cleansing of freshly harvested cannabis, as well as a variety of other herbs, flowers, and tea leaves. Established in 2007, the organization was initially known as Millennium Blockchain, Inc. before officially changing its name to THC Therapeutics, Inc. in September 2018. The company's corporate headquarters are located in Las Vegas, Nevada.

Key people

Victor Nacif
Head of Design · since 2020
John Pierce
Medical Director
Natalia Tafur
Lead Researcher
Scott Cox
Chief Executive Officer, Chief Financial Officer, Director · since 2023
Fiorenzo Villani
Member of the Board of Director · since 2019
URL
https://thct.io/
IPO date
Dec 07, 2007
Employees
Domiciled in
US
Incorporated in
US
Legal address
C/O Joe Lazague, ESQ.
1 East Liberty
Suite 600
Reno, NV 89501
US
Headquarters
11700 West Charleston Boulevard #73
Las Vegas, NV 89135
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2023‑072022‑072021‑072020‑072019‑072018‑072017‑07
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT